BioCanRx - Canada's Immunotherapy Network
@BioCanRx
A Network of Centres of Excellence uniquely positioned to help Canada & the world accelerate the development of effective #cancer #immunotherapy treatments
ID:3226292824
https://biocanrx.com/ 01-05-2015 13:36:28
4,0K Tweets
2,1K Followers
1,4K Following
Congrats to Dr. Uri Tabori of The Hospital for Sick Children (SickKids), & a #BioCanRx network researcher, for throwing out the Toronto Blue Jays ceremonial 1st pitch! 👏⚾️
#ICYMI : Watch our latest #Summit4CISpeakerSeries with #BioCanRx network researcher Dr. Rebecca Auer
Rebecca Auer, MD & lab manager Carole Dore, both of the
The Ottawa Hospital. They share great insights on the impact of reducing carbon footprint in research labs: youtube.com/watch?v=HIJL8z…
A study by researchers Medical University of South Carolina (MUSC) shows overcoming T-cell exhaustion could improve responses to two types of immunotherapies – anti-PD1 therapy and #CARTcelltherapy . Learn more: web.musc.edu/about/news-cen… #CancerResearch #immunotherapy
Great #EarthDay webinar today on greening research labs! Thanks to our speakers Dr. Rebecca Auer Rebecca Auer, MD & Carole Dore of The Ottawa Hospital & thanks to all who attended! If you missed it - stay tuned - in the coming days we'll post the video online. #Summit4CISpeakerSeries
Our #EarthDay #Summit4CISpeakerSeries on reducing carbon footprint in research labs is underway with #BioCanRx network researcher Dr. Rebecca Auer Rebecca Auer, MD & lab manager Carole Dore, both of the The Ottawa Hospital. Learn more: cancersummit.ca/summit-speaker… #CancerResearch #GreenLabs
A phase II clinical trial by researchers University of Hawaii Cancer Center shows promise for maintenance therapy in aggressive #breastcancer . The trial evaluated the safety and effectiveness of pembrolizumab, an immune checkpoint inhibitor, following chemotherapy: uhcancercenter.org/about-us/newsr…
Mark Earth Day with us & our #Summit4CISpeakerSeries ! #BioCanRx network researcher Dr. Rebecca Auer Rebecca Auer, MD & lab manager Carol Dore, both of the The Ottawa Hospital, will join us to talk about reducing carbon footprint in research labs. It's free! Register: bit.ly/3Tle4VD
Budget2024 is a big win for Canadian research. BioCanRx welcomes the announced new funding & key measures to boost research, innovation & productivity that will go a long way to driving Canadian discoveries from the bench to the bedside. canada.ca/en/department-… #CanadianResearch
Congratulations Michel Sadelain! He was honored along with Carl June for their development of chimeric antigen receptor T cell immunotherapy, whereby a patient’s T cells are modified to target and kill cancer cells. @academymuseum Breakthrough #breakthrough Memorial Sloan Kettering Cancer Center
Dr. Michel Sadelain receives 'Oscars of Science' Breakthrough for CAR T cell therapy. Learn more in this Barron's story: barrons.com/news/french-ca… Living Drugs
Congratulations to Michel Sadelain, MD, PhD, FAACR, of Memorial Sloan Kettering Cancer Center, awarded the Gairdner Foundation International Awards today for his work on CD19-CAR T cell therapy for cancer, along with Zelig Eshhar, PhD, Weizmann Institute. #AACRFellows
At the AACR annual meeting, cancer vaccines get a reintroduction as readouts support 'path forward' for the tech. Read more in this FierceBiotech report: fiercebiotech.com/biotech/aacr-2… #AACR24 #CancerResearch
Attention patient partners! Are you passionate about informing #CancerResearch in Canada? The Institute of Cancer Research is seeking a patient representative for our Institute Advisory Board.
If you are interested, e-mail us at [email protected]. Application deadline is April 25.
Our next #Summit4CISpeakerSeries is on Earth Day! We'll be joined by #BioCanRx network researcher Dr. Rebecca Auer Rebecca Auer, MD & lab manager Carol Dore - both of the The Ottawa Hospital to learn about reducing carbon footprint in research labs. Join us! Register: bit.ly/3Tle4VD